Skip to content

Duration of Behavioral Counseling Treatment Needed to Optimize Smoking Abstinence

Duration of Behavioral Counseling Treatment Needed to Optimize Smoking Abstinence

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01038414
Acronym
EDC
Enrollment
450
Registered
2009-12-24
Start date
2008-02-29
Completion date
2013-01-31
Last updated
2011-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco Addiction

Brief summary

The purpose of this study is to determine if extending the behavioral smoking-cessation treatment period to one year will significantly improve cessation outcomes among those planning a quit attempt.

Interventions

BEHAVIORALExtended Duration Behavioral Smoking Cessation Counseling

Subjects are randomized to one of 3 behavioral treatments: (1) Brief Duration (3 month) smoking-cessation counseling; (2) Moderate Duration (6 month) counseling; or (3) Extended Duration (12 month) counseling

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Harvard University Faculty of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Daily Cigarette Smokers

Exclusion criteria

* Smokers with active atherosclerotic heart disease, severe cardiac arrhythmias, uncontrolled hypertension, severe peripheral vascular disease, pre-controlled diabetes mellitus, pregnancy, lactation or likely to become pregnant during the study period, and chronic dermatologic disease. * Smokers who meet DSM-IV lifetime criteria for conditions such as schizo-affective disorder and schizophrenia, bi-polar disorder, or who have had alcohol or drug dependence issues within the past year.

Design outcomes

Primary

MeasureTime frame
Proportion of subjects abstinent by treatment group at 1 year post-cessation.One year

Secondary

MeasureTime frame
Proportion of subjects abstinent by treatment group at 2 years post-cessation.Two years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026